The research group "Molecular Tumor Pathology" is currently funded by:
Roche. Project 1: Characterisation of malignant diseases with FoundationOne Assay (2019-2021)
Novartis. Project 2: Status of PIK3CA mutations from archival primary tumor and matched archival metastatic samples in HR+/HER2- breast cancer from the biobank established (2019-2021)